← All stocks

COMPASS Pathways plc

CMPS Net selling
CIK 0001816590 #2076 in the set updated 20 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$28.74M
$12.24M on a plan · $0.00 straight out of an exercise
Sold at will
$16.50M
11 of 91 sales
Net
−$28.74M
−$16.50M against sales at will

By person

10 insiders · 91 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ATAI Life Sciences N.V.
10% owner
$16.09M (1)
−$16.09M
6,905,774
$41.78M
−27.8%
Goldsmith George Jay
10% owner
$6.28M (44) scheduled
−$6.28M
6,307,970
$38.16M
−26.0%
Malievskaia Ekaterina
10% owner
$6.28M (44) scheduled
−$6.28M
6,307,970
$38.16M
−26.0%
Jenkins Annalisa
Director
$42.23K (1)
−$42.23K
19,480
$117.85K
−17.9%
Norton David Y
Director
$42.23K (1)
−$42.23K
20,356
$123.15K
−14.3%
Nath Kabir
Chief Executive Officer
361,028
$2.18M
Loxam Teri
Chief Financial Officer
152,002
$919.61K
OWENS MATTHEW A
General Counsel & CLO
43,340
$262.21K
FALVEY MICHAEL
Chief Financial Officer
22,500
$136.13K
Goodwin Guy
Chief Medical Officer
8,000
$48.40K

No percentages here. This company's share count has moved by a factor of 2.0 over the window, from 68,420,818 to 138,476,822 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Goldsmith George Jay
24 Oct 2024
10% owner
Sell indirect
776,565
no price
Goldsmith George Jay
24 Oct 2024
10% owner
Sell
776,565
no price
Malievskaia Ekaterina
24 Oct 2024
10% owner
Sell indirect
776,565
no price
Malievskaia Ekaterina
24 Oct 2024
10% owner
Sell
776,565
no price
ATAI Life Sciences N.V.
26 Sep 2024
10% owner
Sell indirect
2,660,000
$6.05
$16.09M
Jenkins Annalisa
29 Mar 2022
Director
Sell
3,384
$12.48
$42.23K
Norton David Y
29 Mar 2022
Director
Sell
3,384
$12.48
$42.23K
Goldsmith George Jay
29 Mar 2022
Chief Executive Officer
Sell indirect
6,372
$12.48
$79.52K
Goldsmith George Jay
29 Mar 2022
Chief Executive Officer
Sell
6,372
$12.48
$79.52K
Malievskaia Ekaterina
29 Mar 2022
Chief Innovation Officer
Sell indirect
6,372
$12.48
$79.52K
Malievskaia Ekaterina
29 Mar 2022
Chief Innovation Officer
Sell
6,372
$12.48
$79.52K

What was left out

Form 4 filings counted 115
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 80
Sales straight out of an exercise 0
Sales at will 11
Transactions with no price 4
Shares from compensation/vesting 945,326
Sales filed before the plan box existed 6
History held since 15 Feb 2022